The Human Microbiome and Child Growth - First 1000 Days and Beyond.


Journal

Trends in microbiology
ISSN: 1878-4380
Titre abrégé: Trends Microbiol
Pays: England
ID NLM: 9310916

Informations de publication

Date de publication:
02 2019
Historique:
received: 11 06 2018
revised: 04 09 2018
accepted: 25 09 2018
pubmed: 12 12 2018
medline: 18 12 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

The assembly of microbial communities within the gastrointestinal tract during early life plays a critical role in immune, endocrine, metabolic, and other host developmental pathways. Environmental insults during this period, such as food insecurity and infections, can disrupt this optimal microbial succession, which may contribute to lifelong and intergenerational deficits in growth and development. Here, we review the human microbiome in the first 1000 days - referring to the period from conception to 2 years of age - and using a developmental model, we examine the role of early microbial succession in growth and development. We propose that an 'undernourished' microbiome is intergenerational, thereby perpetuating growth impairments into successive generations. We also identify and discuss the intertwining host-microbe-environment interactions occurring prenatally and during early infancy, which may impair the trajectories of healthy growth and development, and explore their potential as novel microbial targets for intervention.

Identifiants

pubmed: 30529020
pii: S0966-842X(18)30204-X
doi: 10.1016/j.tim.2018.09.008
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-147

Subventions

Organisme : Wellcome Trust
ID : 108065/Z/15/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206455/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M007367/1
Pays : United Kingdom

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Ruairi C Robertson (RC)

Centre for Genomics & Child Health, Blizard Institute, Queen Mary University of London, UK. Electronic address: r.robertson@qmul.ac.uk.

Amee R Manges (AR)

University of British Columbia, School of Population and Public Health, Vancouver, BC, Canada; British Columbia Centre for Disease Control, Vancouver, BC, Canada.

B Brett Finlay (BB)

Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada.

Andrew J Prendergast (AJ)

Centre for Genomics & Child Health, Blizard Institute, Queen Mary University of London, UK; Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH